Windtree Therapeutics Inc
WINT
WINT was delisted on the 4th of May, 2017.
58 hedge funds and large institutions have $59.8M invested in Windtree Therapeutics Inc in 2015 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 12 increasing their positions, 18 reducing their positions, and 9 closing their positions.
584% more call options, than puts
Call options by funds: $841K | Put options by funds: $123K
22% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 9
4% more funds holding
Funds holding: 56 → 58 (+2)
1% more capital invested
Capital invested by funds: $59.1M → $59.8M (+$657K)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
33% less repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 18
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GTC
Ghost Tree Capital
New York
|
+$3.52M |
| 2 |
TI
Turner Investments
Berwyn,
Pennsylvania
|
+$725K |
| 3 |
ACP
Acuta Capital Partners
Redwood City,
California
|
+$553K |
| 4 |
PRCM
Pine River Capital Management
Minnetonka,
Minnesota
|
+$281K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$136K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TCM
Tamarack Capital Management
Carlsbad,
California
|
-$1.78M |
| 2 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
-$1.22M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
-$838K |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$600K |
| 5 |
Millennium Management
New York
|
-$457K |
WINT Hedge Fund Activity: Q1 2015 in Review
58 of the 3,754 institutional investors tracked by Wall St. Rank reported a position in Windtree Therapeutics Inc (WINT) for Q1 2015, worth a combined $59.8M — up 1.1% from $59.1M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new WINT positions and 9 closed out — a net gain of 2 holders — while 12 added to existing stakes and 18 trimmed.
The largest buyer was Ghost Tree Capital, opening a new position worth an estimated $3.52M. The largest seller was Tamarack Capital Management, cutting an estimated $1.78M.
- 58 institutional investors held Windtree Therapeutics Inc (WINT) as of Q1 2015, up from 56 in Q4 2014.
- Funds reported $59.8M of Windtree Therapeutics Inc stock for Q1 2015, up 1.1% quarter-over-quarter.
- 11 funds opened new Windtree Therapeutics Inc positions in Q1 2015 and 9 closed out, a net change of +2 holders.
- The largest Windtree Therapeutics Inc buyer in Q1 2015 was Ghost Tree Capital, an estimated $3.52M added.
- The largest Windtree Therapeutics Inc seller in Q1 2015 was Tamarack Capital Management, an estimated $1.78M sold.
Based on aggregated 13F filings for Q1 2015.